Point-of-care tests have been available to clinicians and consumers for decades, but more recently, molecular testing technologies that can be used .. Read more at the point of care are making inroads. For now, these molecular point-of-care tests are used largely for infectious disease testing, especially for the flu, and, more recently, COVID-19. But new technology developments are driving applications in new disease areas and end markets, including physician offices, emergency rooms, and CLIA-waived settings.
- [ Users who have shown interest for this Event ]
- Share your Experience